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Abstract
Purpose Voice problems are common after thyroidectomy. The aim of this study was to assess the voice related quality of
life after thyroidectomy with neuromonitoring. The sociodemographic and treatment factors influencing the quality of voice
after the operation were investigated.
Methods A total of 40 patients after thyroidectomy with neuromonitoring were enrolled into the study. The voice outcome
was analyzed pre and postoperatively by two validated self-assessment questionnaires: Voice Handicap Index and Voice-
Related Quality of Life survey.
Results All external branches of the superior laryngeal nerve were identified during the operation. There were no recurrent
laryngeal nerve palsies. The mean total VHIs before and after thyroid operation were 1.2 [SD 2.564] and 2.8 [SD 6.944],
respectively (p= 0.5). Preoperatively, the mean overall score for the V-RQOL was 99.6; postoperatively 98.7 (p= 0.05). A
strong correlation between the V-score of the V-RQOL and O-score of the VHI before and after thyroidectomy was observed
(both p < 0.001).
There was no correlation between V-RQOL or VHI and sex, the kind of thyroid operations, diagnosis, thyroid function,
the mean volume of the goitre, the presence of retrosternal position and the extent of thyroid operations (p > 0.05). A small
correlation between the mean age of the patients and postoperative O-Score of the VHI (p= 0.007650) and between the
mean age and postoperative V-Score for the V-RQOL (p= 0.00648) was observed.
Conclusions The use of neuromonitoring in thyroid surgery is beneficial for patients to improve voice quality. The iden-
tification and preservation of EBSLNs is crucial to eliminate altered voice after thyroidectomy.
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Introduction
There are many indications for surgical treatment of the
thyroid gland. Thyroidectomy is usually recommended in
multinodular goitre with compressive symptoms, dyspnoea
or dysphagia, or in Graves’ disease with orbitopathy and is
a treatment of choice in malignancy or suspicious findings
on fine needle aspiration biopsy (FNAB).
In recent years, an increase in the rate of thyroid surgery
has been observed. For example, in the last three decades,
the rate of thyroid operations has tripled in the United
States [1]. Moreover, more operations are performed due to
thyroid cancer, thanks to better access to ultrasound
examinations and FNAB. These examinations have
increased the identification of malignancy in nodules from
15 to 50%, particularly in small papillary cancers [2]. The
extent of surgery (total vs. subtotal) has been controversial
until recently [3], but currently, total thyroidectomy is
recommended in most high-volume thyroid surgery
units [4, 5]. A perfectly performed total thyroidectomy is
based on complete thyroid mass removal, with central neck
dissection in case of thyroid cancer, with preservation of
parathyroid gland function and anatomical course and
function of recurrent laryngeal nerves. However, thyroid
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operations are still associated with complications and the
impact of these surgeries on the voice determines the quality
of life after them [6]. There are many causes of
thyroidectomy-related voice changes. The most common
are injuries of the recurrent laryngeal nerve (RLN) and
external branch of the superior laryngeal nerve (EBSLN). In
some patients, the voice after thyroid surgery is changed by
cricothyroid muscle injury, strap muscle injury or local
haematoma, or intubation-related injury can happen [6].
The consequences of voice-related changes after thyroid
surgery constitute an impairment of the quality of life. In
the case of RLN injuries, patients claim a hoarse voice,
breathy voice or vocal fatigue. Injury of the EBSLN
either reduces the ability to produce high frequency tones or
causes a hoarse and breathy voice [7, 8]. It is difficult to
estimate the true number of vocal complications, because
not all patients after thyroid surgery have undergone lar-
yngoscopy [9]. According to a systemic review of 27
articles (25,000 patients after thyroid operations), the inci-
dence of temporary vocal fold palsy was 9.8% and the
incidence of permanent RLN palsy was 2.3% [10]. The
prevalence of EBSLN injury is much more difficult to
assess due to limited data and difficult laryngeal exami-
nations to confirm these complications. The only definitive
way to diagnose EBSLN injury is cricothyroid muscle
electromyography. In the literature we find that the pre-
valence of this injury varies from 0 to 58%. These com-
plications are the most commonly underestimated morbidity
after thyroidectomy [8]. Moreover, voice changes
may occur after thyroidectomy without evident laryngeal
nerve injury [6]. Thus, patients should be made aware of
possible mild changes in the voice after thyroid surgery
without any recurrent laryngeal nerve complications.
Taking into account the fact that the voice is an essential
part of human communication, it especially should
be taken care of pre-, intra- and postoperatively, according
to the clinical guidelines by Chandrasekhar et al.
[6]. An evaluation of the voice quality of life after thyroid
surgery gives surgeons some useful information about the
quality of treatment.
There are some publications about the voice quality of
life after thyroid surgery, but none of them takes into
account the use of intraoperative neuromonitoring (IONM)
during thyroidectomy. In recent years, IONM has been
standardized and has gained acceptance among surgeons
during thyroid operations. Neuromonitoring has
broadened our knowledge on RLN anatomy, facilitated
routine RLN identification and positively influenced the rate
of RLN and EBSLN injuries. Currently, there is no doubt
that IONM should be used in difficult thyroid surgery, in
particular in redo surgery, thyroid cancers and Graves’
disease operations, where the risk of RLN injury is extre-
mely high [7, 8].
The aim of this study was to assess the voice-related
quality of life after thyroid surgery with the utilization of
neuromonitoring.
Material and methods
This prospective clinical study included 40 patients, who
underwent thyroid operations with the utilization of IONM
at the Department of General, Gastroenterological and
Endocrine Surgery at Wroclaw Medical University between
January 2015 and July 2017.
Before surgical treatment, all patients were precisely
diagnosed and treated by a general practitioner or endocri-
nologist. All patients were euthyroid; TSH (thyroid-stimu-
lating hormone) and fT4 (free thyroid hormones) were
measured before the operations. In the case of hyperthyr-
oidism before the operations, the patients were treated with
antithyroid drugs and/or in the case of Graves’ disease,
radioiodine therapy was used. We did not give Lugol’s
liquid to patients with hyperthyroidism in the process of
preparation. In all patients, before thyroid surgery ultra-
sonography examinations and chest X-ray were performed.
FNAB was performed to find any suspicious tissues in the
nodular goitre. All patients received informed consent prior
to surgical treatment with information on possible compli-
cations related to both RLN and EBSLN injury.
Patients enrolled into the study were operated on with
IONM. The Nerve Integrity Monitoring System (NIM-3,
Medtronic Xomed, Jacksonville, FL, USA) with endo-
tracheal Flex tubes size 7.0 or 7.5 was used in the study. To
test the nerves, intermittent neuromonitoring was used. The
nerves were stimulated by a single-use, monopolar stimu-
lator probe, set at 1 mA to 2 mA, impulse duration at 100 μs
and frequency at 4 Hz. The monitor was set for an event
threshold of 100 μV. Both RLNs and EBSLNs were mon-
itored with the approach recommended by the International
Neural Monitoring Study Group [7, 8]. The standard of
IONM was carried out using a typical 6-step procedure: L1,
V1, R1, R2, V2, L2, which means that all patients before
and after surgery underwent laryngoscopy; vagal and
recurrent laryngeal nerves were evaluated before and after
removing the goitre. In the case of EBSLN monitoring,
CTM (cricothyroid muscle) twitch was evaluated. For both
RLN and EBSLN, positive signal/stimulation was recog-
nizable when the electromyographic waveform was higher
than 100 μV.
All thyroid operations were performed by a single high-
volume thyroid surgeon (B.W.), who performs more than
100 thyroid operations per year.
Patients enrolled into the study underwent preoperative
direct laryngoscopy. All of them had correct vocal cord
function. Vocal cord palsy recognized preoperatively was
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the exclusion criteria. All patients after thyroid operations
had direct laryngoscopy by an independent laryngologist.
In order to evaluate the quality of voice, the surveys were
completed by all patients before and about 2 months after
the operation.
Voice-Related Quality of Life (V-RQOL) Survey shows
how a voice problem could interfere with daily activities.
There are ten questions about problems related to the voice
in the survey which evaluates how severe this problem is
and how frequently it happens using a 1–5 scale (5 repre-
senting the most serious situation). The answers are based
upon average voice quality for the past 2 weeks. By adding
all of the points, the patient’s own voice-related quality of
life (V-RQOL) can be estimated. The scale ranges from 0 to
100, with 100 being the best result—'excellent', 75—'fair to
good', 50—'poor to fair' and 25—'poor'. The V-RQOL was
adapted from the 'V-RQOL Measure' from the Vocal Health
Center at the University of Michigan Health System. The
10-item V-RQOL measure performs well in tests of relia-
bility, validity, and responsiveness, and it carries a low
burden [11]. In the study, the Polish version of the V-RQOL
was used, which is easy to perform in clinical practice [12].
To sum up, the survey scoring algorithm for V-RQOL
measure was used [11].
Voice Handicap Index (VHI) was developed and vali-
dated in 1997 by Jacobson [13]. It is a 30-item self-admi-
nistered questionnaire to quantify the patient’s perception of
disability resulting from voice disorders. This survey con-
sists of three parts, the functional, physical and emotional
aspects of voice disorders. The functional (F-VHI) subscale
refers to patient communication problems, the emotional (E-
VHI) subscale describes patient affective responses to voice
disorder and the physical (P-VHI) one relates to patient
perception of his or her voice. All the questions are admi-
nistered by patients themselves regardless of the type of
their voice disorder in a five-point scale manner for each
item (from 0= never to 4= always). Patients with severe
voice disorder would gain higher total VHI scores (max-
imum 120). A VHI score between 0–30 reflects a minimal/
mild VHI, 31–60 a moderate VHI, and between 61 and 120
a severe voice handicap. It is a valid and reliable instrument
for assessing the self-perception of a patient’s voice han-
dicap [14]. In the study, the Polish version of the voice
handicap index was used [15].
The Bioethics Committee of Wroclaw Medical Uni-
versity in Poland approved the protocol of this study.
The data were entered into a Microsoft Office Excel 2007
(Microsoft Corp) worksheet, and statistical analysis was
performed using the Statistical Package R 3.2.2 (The R
Foundation for Statistical Computing, Auckland, New
Zealand). The data from the V-RQOL and VHI scales were
correlated with sociodemographic characteristics (age, sex)
and treatment-related variables (diagnosis, thyroid function
category, goitre volume and surgery category) as well as
with each other using the Spearman rho, U Mann–Whitney
and binomial nonparametric tests. A p value less than 0.05
was considered significant.
Results
Patients’ sociodemographic and treatment details
The completed questionnaires were received from 40
patients who underwent thyroid operation with the appli-
cation of IONM. All questionnaires were completed before
and in the second month after the operation. There were 30
women and 10 men with a mean age of 53.8 years (range:
18–74). Among them 35 (87.5%) underwent primary thyr-
oid operations and 5 (12.5%) were reoperated on due to the
recurrence of multinodular goitre many years after the first
operation. The indications for thyroid operations were:
multinodular goitre—26 (65%), toxic multinodular goitre—
3 (7.5%), Graves’ disease—3 (7.5%), thyroid carcinoma—8
(20%). The following thyroid operations were performed: 3
(7.5%) lobectomies, 29 (72.5%) thyroidectomies, 8 (20%)
thyroidectomies with central lymph node clearance (level
VI). All detailed demographic and intraoperative data are
shown in Table 1.
Table 1 Demographic characteristics and intraoperative information
of the patients enrolled in the study
Patients, number 40 (100%)
Recurrent laryngeal nerves at risk, number 77
Mean age (range) 53.8 (18–74)
Female, number 30 (75%)
Male, number 10 (15%)
Primary operations, number 35 (87.5%)
Reoperations, number 5 (12.5%)
Volume of the goitre mean, range (ml) 51.325 (12–146)
Retrosternal goitre, number 27 (67.5%)
Benign disorders—32 (80%)
Nodular goitre, number 26 (65%)
Toxic nodular goitre, number 3 (7.5%)
Graves’ disease, number 3 (7.5%)
Thyroid carcinoma—8 (20%)
Papillary thyroid carcinoma, number 7 (17.5%)
Poorly differentiated thyroid carcinoma, number 1 (2.5%)
Thyroid operations
Lobectomy, number 3 (7.5%)
Thyroidectomy, number 29 (72.5%)
Thyroidectomy with lymphadenectomy, number 8 (20%)
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Thyroid operation with neuromonitoring
All RLNs and EBSLNs were identified in all patients. In
one patient, transient loss of signal was observed during the
operation with the recovery of the signal within 10 min. The
proper movement of vocal cords before and after thyroid
operations was confirmed in all patients. In two patients,
postoperative hypoparathyroidism was treated with calcium
intravenous supplementation. There were no bleeding
complications after the thyroid surgery.
VHI scale
The mean total score (T-VHI) before and after thyroid
operation were divided into individual domains: mean
functional score (F-VHI), a physical score (P-VHI) and an
emotional (E-VHI) score and were presented in Table 2.
The binomial test revealed that the null hypothesis cannot
be rejected, which means that the number of the patients
who got VHI score= 100 (and <100 respectively) was not
significantly different before and after the treatment. It is
shown in Table 2.
The overall VHI scores before and after thyroid surgery
were assigned to one of three groups (minimal, moderate or
severe degree of handicap). Before thyroid surgery, all
patients had the minimal degree of handicap (100%). After
thyroid surgery, only one patient was handicapped, to a
moderate degree (2.5%).
V-RQOL scale
Before thyroid operations, the mean overall score (V score)
for the V-RQOL scale was 99.6 with mean social-emotional
domain (SE-d) 100 and physical-functional domain (PF-d)
99.2. Postoperatively, the mean V score was 98.7 with a
mean SE-d 99.8 and PF-d 97.8. The binomial test revealed
that the null hypothesis cannot be rejected, which means
that the number of the patients who got V-RQOL score=
100 (and <100 respectively) was not significantly different
before and after the treatment. This is shown in Table 3.
The overall scores for the V-RQOL were analysed. All
patients before and after thyroid operations were qualified
into the 'excellent' group.
Correlation between VHI and V-RQOL
The scores from the VHI and V-RQOL were compared.
There was a strong correlation between V-score V-RQOL
and Overall score of the VHI before thyroid surgery
(Spearman rho −0.68) and after thyroidectomy (Spearman
rho −0.77); both p values < 0.001. (Figures 1 and 2).
Correlation between VHI, V-RQOL and
sociodemographic and treatment data
There was no correlation between V-scores for the V-
RQOL or the O-Score of the VHI and sex, the kind of
Table 2 Results of descriptive
statistical analysis for voice self-
assessment variables before and
after thyroidectomy
Before thyroid operation After thyroid operation
Number of patients Min Max Mean SD Min Max Mean SD p-value
F-VHI 40 0 3 0.2 0.564 0 7 0.55 1.358 0.5
P-VHI 40 0 7 0.8 1.683 0 21 1.82 4.562 0.5
E-VHI 40 0 3 0.2 0.608 0 8 0.43 1.430 1
T-VHI 40 0 10 1.2 2.564 0 36 2.8 6.944 0.5
Differences in mean scores of voice self-assessment variables before and after thyroidectomy
SD standard deviation, Min minimum observed score, Max maximum observed score
p-value—calculated probability, results of exact binomial (two-tailed) used to examine differences in the
number of patients with VHI= 0 before and after thyroidectomy
Table 3 Results of descriptive statistical analysis for voice-related quality of life before and after thyroidectomy
Before thyroid operation After thyroid operation
V-RQOL score Number of patients Min Max Mean SD Min Max Mean SD p-value
Social-emotional domain 40 100 100 100 0.158 94 100 99.8 0.949 1
Physical-functional domain 40 96 100 99.2 1.176 79 100 97.8 4.802 0.5
Total 40 98 100 99.6 1.279 85 100 98.7 3.083 0.5
Differences in mean scores of V-RQOL before and after thyroid surgery
SD standard deviation, Min minimum observed score, Max maximum observed score
p-value—calculated probability, results of exact binomial (two-tailed) used to examine differences in the number of patients with V-RQOL score
= 100 of voice self-assessment variables before and after thyroidectomy
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thyroid operation (primary, reoperations), diagnosis, thyroid
function (euthyroidism/hyperthyroidism), the mean volume
of the goitre, the presence of retrosternal position and the
extent of thyroid operations (lobectomy, thyroidectomy)
(Spearman R, p > 0.05). We found only a small correlation
between the mean age of the patients and postoperative the
O-Score of VHI (Spearman R, p= 0.007650) and between
the mean age and postoperative V-Score for the V-RQOL
(Spearman R, p= 0.00648).
Discussion
Voice complications after thyroid surgery have been
repeatedly evaluated in the literature [6–8, 16]. Despite
many years since thyroid surgery was first considered quite
safe, altered voice is still a problem for both patients and
surgeons. About one in ten patients experiences temporary
laryngeal nerve injury after surgery with longer lasting
problems in up to 25% of cases. Previous data have shown
that 25% to almost 90% of patients report abnormal voice in
the first period after the operation and 11–15% have per-
manent voice problems in the first 6 months postoperatively
[6, 16]. Recurrent laryngeal nerve injuries are the main, but
not the only factor influencing voice quality of life after the
operations. Other less common causes of voice impairment
include strap muscle injury, oedema or airway management
[17]. Moreover, it is worth emphasizing that temporary
hoarseness happens in any surgery with general anaesthesia,
but in the case of thyroid surgery it always arouses suspi-
cion of RLN injuries [18]. Neuromonitoring distinguishes
RLN damage due to surgery from anaesthetic, but it is not
possible to distinguish other subtle reasons for voice
changes. We excluded patients from the study with difficult
intubation or oedema after intubation. Thus, early, appro-
priate recognition of voice problems after thyroidectomy is
beneficial for patients in order to be able to get the right
treatment.
In order to improve voice outcome after thyroid surgery,
it is strongly recommended that a surgeon identify RLN
injuries during the operation [6]. Most surgeons consider
this to be the gold standard, which minimizes the rate of
RLN injuries [6, 19, 20]. The next milestone in thyroid
surgery seems to be the introduction of IONM during the
operation. Nowadays IONM is a common technique which
is gaining more and more acceptance among surgeons as an
adjunct to the routine of visual recurrent laryngeal nerve
injury identification [7]. With the application of IONM, the
rate of RLN injury identification is almost 100% [21–24]
and the incidence of transient RLN palsies is lower, parti-
cularly in difficult thyroid operations [21, 25, 26]. The
introduction of IONM also focused our interest on the
EBSLN [8]. So far, more attention has usually been paid to
the consequences of damage to the RLN than to EBSLN
injury, which is less clearly defined, but could lead to
temporary or permanent voice change as well. It is an injury
which causes the dysfunction of the CTM, resulting in
changes in voice quality and projection, and reduction of
the ability to produce high frequency tones. Some patients
may also have a hoarse breathy voice with increased throat
clearing and vocal fatigue [6, 8, 16]. Although for the
majority of patients, a change of voice dependent on
EBSLN could be discreet or even overlooked, it is a sig-
nificant disability to professional voice users. Until now, the
Fig. 1 Scatter-plot showing correlation between the overall score of
the V-RQOL and the overall score of the VHI scales measured before
treatment. Comment: When the scores for the two questionnaires, V-
RQOL and VHI, before and after treatment were compared using
Spearman rho correlation test, an inverse correlation was found
between the overall V-RQOL scores and the overall VHI scores
(Spearman rho > 0.6, p < 0.001)
Fig. 2 Scatter-plot showing correlation between the overall score of
the V-RQOL and the overall score of the VHI scales measured after
treatment. Comment: When the scores for the two questionnaires, V-
RQOL and VHI, before and after treatment were compared using
Spearman rho correlation test, an inverse correlation was found
between the overall V-RQOL scores and the overall VHI scores
(Spearman rho > 0.6, p < 0.001)
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problem of injuries of the EBSLN has been neglected,
because the diagnosis of its injury is difficult to confirm in
solely postoperative laryngoscopy. Only laryngeal electro-
myography makes it possible to diagnose nerve injury and
to evaluate it with high diagnostic certainty [6, 8]. Visual
identification of EBSLN is usually possible in only 80% of
patients undergoing routine dissection and in almost 100%
with the application of IONM [27].
In the literature, there are many publications about voice
assessment and voice-related quality of life in patients after
thyroid operations [6, 16, 17, 28–30] but only a few of them
refer to surgery with IONM [31, 32].
The aim of this study was to assess thyroid operations
with IONM in the context of voice quality after surgical
treatment. For this purpose, we evaluated vocal quality
preoperatively and postoperatively. Among a number of
existing voice-specific symptom scales, we chose two of the
most commonly used instruments: Voice Handicap Index
(VHI) and V-RQOL. The VHI is an instrument that was
developed to quantify the patient’s perceptions of disability
due to vocal dysfunction. The V-RQOL questionnaire is a
self-administered short form patient report instrument which
measures the subjective burden elicited by voice disorders.
Both questionnaires have proved to have good reliability
and validity for a range of voice disorders [11, 33].
To precisely assess even subtle changes of voice after
thyroidectomies, all the patients had a thorough post-
operative laryngoscopy. Our study shows that the mean
functional, physical, emotional and total scores before and
after thyroidectomy were different, but the differences were
not statistically significant (0.2 vs. 0.55, p= 0.5; 0.8 vs.
1.82, p= 0.5; 0.2 vs. 0.43, p= 1; 1.2 vs. 2.8, p= 0.5).
Similarly, there were no statistical differences between the
mean V-score for V-RQOL before and after surgery (99.6
vs. 98.7, p= 0.5). We did not observe any statistically
significant differences in the socio-emotional or physical
functioning domain (100 vs. 99.8, p= 1; 99.2 vs. 97.8,
p= 0.5). The biggest change between the preoperative and
postoperative period concerned the physical or physical
functioning domains in both questionnaires. A very strong
correlation between VHI and V-RQOL before (−0.68
Spearman R) and after surgery (−0.77 Spearman) was
found in the group of patients. It should be emphasized that
almost all the patients after thyroid operations were handi-
capped to a minimal extent according to the VHI scores and
have an 'excellent' V-score of the V-RQOL. Our data show
that voice changes after thyroid surgery with the utilization
of IONM are subtle, almost imperceptible to the patients. It
seems that EBSLN identification and preservation has a
significant impact on voice quality. It is very difficult to
distinguish surgical reasons vs. non-surgical ones for voice
changes without the use of IONM. Our study confirms that
thyroid surgery with IONM, with positive responses from
RLN and EBSLN during the operations, is on the top of
quality treatment. Our results are similar to those observed
by Randolph [30] and Su-jin Kim [29] during thyroid sur-
gery with IONM. Randolph et al. assessed the quality of the
voice after thyroidectomy with the use of IONM in a pro-
fessional singer. The voice handicap index mean scores,
pre-op and post-op were unchanged: VHI 4.15 (±5.22) vs.
4.04 (±3.85), p= 0.9301. Subsequent tests (Singing Voice
Handicap Index—SVHI and Evaluation of Ability to Sing
Easily) confirmed the same results as well. The Su-jin Kim
study also shows very good results in voice quality after
EBSLN identification. This author used IONM to identify
EBSLN injury during bilateral axilla‒breast approach
robotic thyroid surgery. VHI-10 showed a change of voice
over time (0.1 vs. 3.6 vs. 1.3), however, this was not sta-
tistically significant. These authors also emphasize the role
of IONM in the preservation of EBSLN and its influence on
the quality of voice.
In the literature there are a lot of publications about the
quality of voice after thyroid surgery before the introduc-
tion of neuromonitoring. In Cvelbar’s study, significant
differences were found between the mean scores on voice
self-assessment variables before and after thyroidectomy.
These differences were found on functional, physical and
total VHI score (F-VHI, P-VHI, T-VHI) [30]. Voice and
swallowing changes after thyroidectomy in patients with-
out inferior laryngeal nerve injuries were assessed in a
Lombardi publication. The mean postoperative voice
impairment scores (VIS) were significantly higher
(p= 0.05) than the preoperative VIS 1 week and 1 month
after thyroidectomy, but not after 3 months. EBSLN was
not assessed in these publications [34]. This may be a
reason why the voice-related quality of life differs sig-
nificantly in pre-op and post-op. This observation confirms
the beneficial effect of IONM on improving voice quality
after surgery.
In our study, we tried to find significant factors influen-
cing VHI and V-RQOL in patients who underwent thyroid
surgery. Only age was found to be a significant predictor of
voice quality with higher voice handicap in the younger
patients. It was weak correlation, but it surprised us. This
may be related to the impact of vocal dysfunction on the
working and social life of younger patients. We did not find
any correlation between other socio-demographic data, the
diagnosis and the kind of thyroid operation.
At the end it is worth mentioning that the authors are
aware of several limitations of the study. The first is the
small group size of patients enrolled ino the study. The 40
patient group is small to strongly support the well-justified
results. Secondly, the voice alteration might be the result of
several other factors (i.e., strap muscles injury or intubation)
which are difficult to distinguish from voice problems
associated only with the thyroid surgery.
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However, the lack of research on this subject prompted
us to summarize our data and the review of current literature
on the subject. Since the IONM is more and more accepted
in many countries, not only the rate of RLN or EBSLN
injuries, but also the voice quality of life should be taken
into consideration.
Conclusion
The use of neuromonitoring in thyroid surgery is beneficial
for patients to help safeguard against loss of voice quality.
The identification and preservation of EBSLN seems to be
crucial to eliminate altered voice after thyroidectomy. VHI
and V-RQOL are simple, easy to use and are comparable
measures about the voice after thyroid operation. This gives
us important and useful information about physical, func-
tional and emotional voice outcomes after thyroidectomy.
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